Prosetta Bioconformatics Pvt Ltd

Innovating the Future of Medicine | Tackling AMR, Viral, & Neurodegenerative Diseases. Founded in 2004, Prosetta Bioconformatics Pvt Ltd is a cutting-edge biotech and pharmaceutical research company based in Mysuru, India. As a subsidiary of Prosetta Biosciences Inc., we are pioneering the discovery and development of novel small-molecule drugs to combat some of the world’s most urgent and unmet medical challenges, from antimicrobial resistance (AMR) and viral pandemics to cancer and neurodegenerative disorders. Breakthrough Science | Real-World Impact Our proprietary Prosetta Paradigm and Platform have enabled us to uncover first-in-class and best-in-class small molecules with unprecedented activity against: ✅ Pan-family viral infections ✅ Multi-drug-resistant (MDR) bacterial infections ✅ Fungal & parasitic infections ✅ Malignant cancers & inflammatory diseases ✅ Neurodegenerative disorders Revolutionizing Antibiotic Discovery One of our key programs focuses on next-generation broad-spectrum antibiotics, designed to combat high-priority AMR superbugs responsible for deadly community and hospital-acquired infections. With a robust drug discovery pipeline, world-class scientific expertise, and a mission to save lives through innovation, Prosetta Bioconformatics is redefining the future of infectious disease treatment and beyond. 🔬 Join us in shaping the next era of medicine. #Biotech #PharmaInnovation #AntimicrobialResistance #DrugDiscovery #FutureOfMedicine